AU2003264356A1 - Hsp90 FAMILY PROTEIN INHIBITORS - Google Patents
Hsp90 FAMILY PROTEIN INHIBITORSInfo
- Publication number
- AU2003264356A1 AU2003264356A1 AU2003264356A AU2003264356A AU2003264356A1 AU 2003264356 A1 AU2003264356 A1 AU 2003264356A1 AU 2003264356 A AU2003264356 A AU 2003264356A AU 2003264356 A AU2003264356 A AU 2003264356A AU 2003264356 A1 AU2003264356 A1 AU 2003264356A1
- Authority
- AU
- Australia
- Prior art keywords
- family protein
- protein inhibitors
- hsp90 family
- hsp90
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002250056 | 2002-08-29 | ||
| JP2002-250056 | 2002-08-29 | ||
| PCT/JP2003/011087 WO2004024141A1 (en) | 2002-08-29 | 2003-08-29 | Hsp90 FAMILY PROTEIN INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003264356A1 true AU2003264356A1 (en) | 2004-04-30 |
Family
ID=31986249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003264356A Abandoned AU2003264356A1 (en) | 2002-08-29 | 2003-08-29 | Hsp90 FAMILY PROTEIN INHIBITORS |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2004024141A1 (en) |
| AU (1) | AU2003264356A1 (en) |
| WO (1) | WO2004024141A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101970765B1 (en) * | 2017-11-16 | 2019-04-22 | 한국해양과학기술원 | Composition for Preventing or Treating Inflammatory Diseases Comprising Curvularin-Type Metabolites From a Marine Fungi Penicillium sp. SF-5859 |
| CN109010333A (en) * | 2018-11-06 | 2018-12-18 | 杭州医学院 | Dehydrogenation curvularin is inhibiting the application in Hedgehog access |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10218768A (en) * | 1997-02-10 | 1998-08-18 | Asahi Chem Ind Co Ltd | Therapeutic agent for proliferative disease |
| CA2356622A1 (en) * | 1998-12-24 | 2000-07-06 | Novation Pharmaceuticals Inc. | Compounds which affect mrna stability and uses therefor |
| FR2819512B1 (en) * | 2001-01-18 | 2003-02-21 | Servier Lab | NOVEL CYCLO [D] AZEPANE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| JP2005520795A (en) * | 2001-12-12 | 2005-07-14 | コンフォーマ・セラピューティクス・コーポレイション | Purine analogs having HSP90 inhibitory activity |
-
2003
- 2003-08-29 AU AU2003264356A patent/AU2003264356A1/en not_active Abandoned
- 2003-08-29 JP JP2004535890A patent/JPWO2004024141A1/en not_active Abandoned
- 2003-08-29 WO PCT/JP2003/011087 patent/WO2004024141A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2004024141A1 (en) | 2006-01-05 |
| WO2004024141A1 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003202263A1 (en) | Roh-kinase inhibitors | |
| AU2002953255A0 (en) | Protein kinase inhibitors | |
| AU2003249683A1 (en) | Nf-:b inhibitors | |
| AU2003290563A1 (en) | Leptin-related peptides | |
| AU2003261801A1 (en) | Novel depsipeptide compound | |
| AU2002354472A1 (en) | Combine | |
| AU2003295462A1 (en) | Lipid-associated proteins | |
| EP1576115A3 (en) | Protein chips | |
| AUPS251502A0 (en) | Protein kinase inhibitors | |
| AU2003282338A1 (en) | Determination of protein function | |
| AU2003296960A1 (en) | Peptide deformylase inhibitors | |
| AU2003205623A1 (en) | Prion protein carrier-conjugates | |
| AU2002355026A1 (en) | Combine | |
| AU2003268664A1 (en) | Stabilized protein compositions | |
| AU2003304374A1 (en) | Peptide inhibitors of beta-lactamases | |
| AU2003264357A1 (en) | Hsp90 FAMILY PROTEIN INHIBITORS | |
| AU2003264356A1 (en) | Hsp90 FAMILY PROTEIN INHIBITORS | |
| AU2003202694A1 (en) | Torero protein | |
| AU2003254001A1 (en) | Novel htnfsf13b protein variants | |
| AU2003236374A1 (en) | Atopic dermatitis-inducing proteins | |
| AU2003220217A1 (en) | Identifying peptide modifications | |
| AU2003278718A1 (en) | Stars-a muscle-specification-binding protein | |
| AU2003270055A1 (en) | Neurotransmission-associated proteins | |
| AU2003224266A1 (en) | Fish transportation | |
| AU2003300785A1 (en) | Carbohydrate-associated proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |